References

Unresolved reference

External reference

Unresolved reference

External reference

Diagnosis and management of non-cystic fibrosis bronchiectasis

10.7861/clinmed.2021-0651 · 2021 · External reference

Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study

10.1183/13993003.01033-2015 · 2016 · External reference

Mucoactive agents in bronchiectasis: a systematic review and meta-analysis

10.1183/16000617.0014-2026 · 2026 · External reference

Unresolved reference

External reference

Targeting neutrophilic inflammation in obstructive airway disease - a narrative review of brensocatib therapy

10.1016/j.rmed.2025.108243 · 2025 · External reference

Basic, translational and clinical aspects of bronchiectasis in adults

10.1183/16000617.0015-2023 · 2023 · External reference

Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis

10.1164/rccm.201605-1027oc · 2017 · External reference

Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis

10.1056/nejmoa2021713 · 2020 · External reference

Phase 3 trial of the DPP-1 inhibitor brensocatib in bronchiectasis

10.1056/nejmoa2411664 · 2025 · External reference

The effectiveness and value of brensocatib for the treatment of non-cystic fibrosis bronchiectasis

10.18553/jmcp.2026.32.3.392 · 2026 · External reference

Brensocatib in non-cystic fibrosis bronchiectasis: ASPEN protocol and baseline characteristics

10.1183/23120541.00151-2024 · 2024 · External reference

Unresolved reference

External reference

Management of adult bronchiectasis: an American College of Chest Physicians clinical practice guideline

10.1016/j.chest.2026.06.057 · 2026 · External reference

The association between polypharmacy and medication regimen complexity and antibiotic use in bronchiectasis

10.1007/s11096-018-0681-1 · 2018 · External reference

Unresolved reference

External reference